A world class team brimming with
expertise, passion and talent

Every member of our staff is passionate about access for Rare Diseases

Sophie Schmitz

Managing Partner
Read bio

Akshay Kumar

Partner
Read bio

Stuart Tutt

Senior Advisor
Read bio

Aparna Krishnan

Partner - Global Operations
Read bio

Owen Bryant

Creative Director
Read bio

Jeff Parish

Partner - Head of North America
Read bio

Joanna Fernandes

Senior Consultant
Read bio

Sylwia Lach

Senior Consultant
Read bio

Chloe Sheppard

Associate Consultant
Read bio

Richard Wang

Senior Analyst
Read bio

Andrea Bernardini

Senior Analyst
Read bio

Nadia Al Lahiq

Analyst
Read bio

Fisentzos Stylianou

Analyst
Read bio

Olivia Johns

Analyst
Read bio

Georgina Rack

Communications Executive
Read bio

Erfan Akbraian

Operations Assistant
Read bio

Adama Anozie

Analyst
Read bio

Purple is Sophie's power colour

Sophie Schmitz

Managing Partner

Sophie is Managing Partner at Partners4Access, the global access experts for orphan drugs, cell and gene therapy. She brings a wealth of commercial and access experience across orphan and cell and gene therapies to the benefit of clients. She plays an active role in advising clients on price and market access strategies, with the ultimate goal of optimizing fair access for all stakeholders in rare disease.

 

Her 20+ year career spans various disease areas and medical devices, successfully supporting the strategy development and operationalization for orphan drugs. Her extensive industry experience across several product launches ensures clients benefit from that knowledge and build stronger access strategies as a result. Managing global, regional and local teams has provided her with the know-how to successfully face the real-life challenges in today’s orphan, cell and gene therapy world.

Akshay is a big Manchester City supporter

Akshay Kumar

Partner

Akshay is a Partner at Partners4Access. Akshay has 13+ years of experience helping pharmaceutical and biotech companies develop market access & pricing solutions – which are aligned to their broader commercial, organizational and environmental context.

 

These solutions could be at the product, process and/or capability level. Besides market access, Akshay also has supported pharmaceutical companies in allied commercial areas such as – epidemiology, opportunity assessments, product positioning, product performance tracking, customer insights, and organizational design.

 

Prior to joining Partners4Access, Akshay worked at Huron Consulting as Senior Director – Orphan Drugs, Cell & Gene Therapy commercialization and at ZS Associates initially as European Market Access and Pricing Lead and then as Global Epidemiology Practice Lead. He holds a D.Phil (PhD) in Materials from University of Oxford.

Stuart has a project to walk the length of the River Thames

Stuart Tutt

Senior Advisor

Stuart has worked in global and European pricing and market access for over 20 years.

 

Following the acquisition of PriceSpective by ICON in 2012, he was the European Head and Global Head of the Pricing and Market Access consulting team. He has led consulting projects for several large, medium and small biopharma companies, across a wide range of therapy areas and all phases of development, with a focus on in-licensing evaluations, Phase III planning, launch pricing and market access and loss of exclusivity planning. In addition, he has led projects advising clients on internal process and infrastructure.

 

During his industry tenure, he has worked at GSK where responsibilities included pricing and reimbursement strategy for pipeline products, price management of marketed products and managing the in-house price database. Stuart has a degree in mathematics from Oxford University and a masters in Operational Research.

Aparna is a Strictly Come Dancing superfan

Aparna Krishnan

Partner – Global Operations

Aparna has over 10 years’ experience in the pharmaceutical and healthcare industry. As part of the senior leadership team, her primary focus is on  strategic corporate engagement, legal, financial operations and human resources.

 

She has previously worked as Manager, Life Sciences at IHS Markit and as Consultant at Parexel’s Commercialization unit among others specializing in market access, pricing and reimbursement.

 

Aparna has a Bachelors’ degree in Life Sciences and a Masters in International Finance, with a focus on econometric modelling on the pharmaceutical industry.

Owen has always been very interested in history

Owen Bryant

Creative Director

Owen has over 10+ years’ experience of graphic and creative design; his main responsibility at P4A is design and branding for internal and external projects. He studied media and communication at Greenwich University and began a career in recruitment and marketing for consultancy services.

 

Owen moved into local government social services, setting up employment training enterprises for disadvantaged adults. During this time, he developed design and printing services which kick-started Owen’s passion for the creative process and graphic design. Owen started working for P4A as a design consultant for in 2017, collaborating successfully on a number of long-term projects. He was invited to join the team full-time in 2020 as their new Creative Director.

 

Owen believes that successful design begins with honesty, that it asks the right questions and comes from a spirit of collaboration. It is also about being brave and trusting your intuition.

Jeff Parish

Partner - Head of North America

Jeff Parish is the newest P4A partner and heads up P4A’s North American offices. Jeff comes to P4A with an impressive portfolio of roles including Vice President of NOVOS. Jeff specialities include Life Sciences: Corporate, Commercial and R&D Strategy and Operations, Risk Mitigation, LM&A, Managed Markets, Patient Access, Patient Outcomes, Market Access, Analytics, Information Management, Revenue Management, Pricing & Contracting, Sales & Marketing.

 

Jeff is an extremely consciencious and knowledgeable partner. His understanding of the Pharma market is extremely valuable to P4A’s focus on rare diseases. It is rare to find someone as dedicated and truthful as Jeff; he represents the highest mark in integrity. 

 

Jeff is based in New Jersey with his wife and family and enjoys hunting with his dogs.

Joanna loves to travel and discover places around the world

Joanna Fernandes

Senior Consultant

Joanna’s main responsibilities at P4A include developing current and future landscape assessments, market research, and funding analysis, including innovative payment methods. Her key focus is on Cell and Gene therapy but has worked on a number of projects across a range of therapy areas, including immune-oncology, rare and ultra-rare diseases.

 

She has completed a B.Sc. in Biochemistry at Imperial College London, focusing on infectious diseases and biotechnology. Prior to Partners4Access, she worked as an analyst at Finalta, Mckinsey Solutions, allowing her to further develop her primary and secondary research skills.

Sylwia Lach

Senior Consultant

Sylwia has over 8 years of experience in market access and health technology assessment with a strong interest in orphan drugs, gene and cell therapies.

 

At P4A, Sylwia works as a project manager on projects focused on the development of market access strategies, evidence generation plans and access roadmaps for clients in the pharmaceutical and biotechnology industry.

 

Prior to Partners4Access, Sylwia has worked for 6 years for the global market access consultancies (Creativ-Ceutical and Amaris) on various market access and value communication projects for drugs and medical devices in different therapeutic areas, including strategic recommendations and evidence generation plans, primary research, and advisory board meetings, early scientific advice, payer value propositions, value dossiers, HTA, and landscape analyses.

 

Sylwia holds a Master of Public Health from the Jagiellonian University Medical College in Cracow, Poland.

You can take Chloe out of the countryside, but you can’t take the countryside out of Chloe

Chloe Sheppard

Associate Consultant

Chloe has a strong interest in cell and gene therapies and the development of market access, pricing and reimbursement strategies to support the commercialization of such innovations. Previously, Chloe has worked in market access consulting as an analyst, where she conducted both primary and secondary research to support HTA and market access activities in multiple disease areas.

Chloe holds an M.Sc. in Stem Cell and Regenerative Therapies: From Bench to Market from King’s College London, and a B.Sc. in Biology from Royal Holloway University of London. Her M.Sc. thesis on business strategy development for cellular therapy focused on an iPSC-based treatment for age-related macular degeneration.

Richard’s childhood dream was to be a tiger, but it didn’t quite work out

Richard Wang

Senior Analyst

Richard seeks to assist in the development of market access and reimbursement strategies for ATMPs and Orphan Drugs through utilizing primary and secondary research.

During his Pharmacology PhD working on a novel protein-degrader class of drugs at the University of Cambridge, Richard undertook an 3-month internship at Partners4Access where he developed a passion for innovative treatments and equitable access. His time at Partners4Access cemented his desire to help identify and solve client problems in the dynamic ATMP field.

Richard also holds a M.Sci. in Systems Biology, focusing on computational biology, and a B.A. in Natural Science with a specialism in Pharmacology from the University of Cambridge.

Andrea has always loved foraging in nature for cooking ingredients

Andrea Bernardini

Senior Analyst

Andrea’s role at P4A involves conducting primary and secondary research to assist in the development of market access and reimbursement strategies for clients in the pharmaceutical and biotechnology industries.

 

Andrea has a strong interest in developing market access, pricing and reimbursement strategies for orphan drugs and cell and gene therapies. This passion for rare diseases stemmed from his previous experience as a researcher during his Ph.D. in Mechanical Engineering at Imperial College London, where he worked towards the development of a novel drug delivery system to treat Glioblastoma. He also holds a B.Sc. from the University of Pavia (Italy) where he conducted a research on aneurysmal and dissected arteries, further developed during his Erasmus+ research project at Brunel University London. He then obtained a M.Sc. in Bioengineering from the University of Surrey, where he researched the apoptotic processes of red blood cells.

Nadia knows more about London food markets than Gordon Ramsey does

Nadia Al Lahiq

Analyst

Nadia’s work at P4A involves conducting primary and secondary research for landscape and pipeline assessments to support the development of strategies within market access and reimbursement for clients in the pharmaceutical and biotechnology industries.

 

She has a passion for Cell and Gene therapy with a special interest in orphan diseases. Her goal is to help make these therapies more assessable. Nadia has experience in working in healthcare marketing and advertising where she worked closely with clients to deliver promotional and educational materials.

 

Before joining P4A, Nadia achieved an M.Sc. in Stem Cell and Regenerative Therapies: From Bench to Market from King’s College London where she completed a thesis on developing a business strategy to treat Recessive Dystrophic Epidermolysis Bullosa (RDEB), using topically administered allogenic mesenchymal stem cell’s. Nadia also holds a B.Sc. in Biomedical Sciences from Royal Holloway University of London.

If you know more about tomatoes than Fisentzos, then you must be one

Fisentzos Stylianou

Analyst

Fisentzos’s role at Partners4Access includes conducting primary and secondary research to support the development of market access and reimbursement strategies for clients in the pharmaceutical and biotechnology industries. With a passion for innovative treatments, he closely follows the cell and gene therapy field as it expands to treat more patients with rare diseases.

 

Prior to joining Partners4Access, Fisentzos worked as a Research Associate at Imperial College London, where he also earned his Ph.D. in Structural Biology in 2020. During this time, he conducted research as part of a multidisciplinary team to advance his understanding of the structure and function of biofilm-forming proteins, paving the way for the design of novel antimicrobial therapeutics. Fisentzos also holds an M.Sc. in Biomedical and Molecular Sciences Research and a B.Sc. in Biomedical Science, both from King’s College London.

Olivia was once told she could be a successful artist (by her mum)

Olivia Johns

Analyst

Olivia’s role at P4A is to assist in the development of market access and reimbursement strategies through primary and secondary research on Orphan Drugs and ATMPs.

 

With a B.Sc. in Global Health and Social Medicine from King’s College London, Olivia has studied health within both the social sciences and the life sciences. This interdisciplinary background aids her consideration for a broad range of perspectives when finding solutions to complex problems. She has a special interest in neuroscience and the ethics of emerging biotechnologies, both areas of specialism within her B.Sc.

Georgie Rack dances like a drangonfly in the middle of summer

Georgina Rack

Communication Executive

Georgina has over 8 years’ experience working in the Pharmaceuticals & Healthcare industry, with a strong background in organizing events. At P4A, her role includes conference and promotional activities, marketing efforts and admin tasks.

 

She has previously worked for the Conservative Party, under David Cameron and worked through two UK General Elections and assisted with organising two Conservative Party Conferences. After this, Georgie moved to ICON under the Pricing & Market Access Team and gained knowledge in contracts, honoraria payments, conferences & ad boards, as well as admin tasks assisting the Senior Leadership Team.

Erfan is P4A’s reigning Fantasy Football Premier League champion

Erfan Akbraian

Operations Associate

Erfan’s role at Partners4Access includes conducting primary and secondary research to support the development of market access and reimbursement strategies. He has a passion for innovations within neuroscience and the cell and gene-therapy space.

 

Erfan holds a B.Sc. in Biomedical Science from the University of Southampton and a M.Sc. in Neuroscience from King’s College London where he conducted a full-time research project within the KCL Neuroscience laboratory.

Fighting evil by moonlight, enabling market access by daylight

Adama Anozie

Analyst

Utilising primary and secondary research, Adama assists in the development of market access and reimbursement strategies for ATMPs and Orphan Drugs. 

 

Adama achieved an M.Sc. in Drug Development and Pharma Management from University College London, during which she undertook a 2-month internship at Parnterns4Access and developed an enthusiasm for securing sustainable patient access to innovative therapies. Her thesis explored the feasibility of CAR-T therapy development for Pharma, with a focus on the potential impact of Hospital Exemption (HE) use as a means of decentralization in CAR-T therapy development and manufacturing.

 

Adama also holds a B.Sc. in Pharmacology and Therapeutics from McGill University (Canada), first sparking her passion for pharmaceuticals, and a B.Pharm from the University of Manitoba (Canada), where she trained to navigate the healthcare system at the ground level by working in both hospital and community Pharmacy. Her extensive knowledge of the science behind pharmaceuticals and the applicability of scientific innovation within clinical practice allows her a well-rounded approach to complex problem-solving.